Nuance | GenomeWeb


Nuance's CLU solution, which includes natural language processing capabilities that are tailored to the healthcare space, will "supplement" Watson's more general NLP abilities.

"What we're going to need to fully take advantage of Watson is to have the genetic and epigenetic information of patients so that the Watson program will be able to utilize and organize that also in medical decision making," said a researcher involved with IBM's efforts to develop an artificial intelligence system that can help doctors diagnose patients accurately and quickly.

The firms will combine technology that IBM developed for Watson, including deep question answering, natural language processing, and machine learning capabilities, with Nuance's speech recognition and Clinical Language Understanding solutions to help physicians diagnose and treat patients.

The partners will combine their respective technologies in an effort to provide hospitals, physicians, and payers access to critical and timely information with a potential role in personalized medicine.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.